Success Metrics

Clinical Success Rate
78.6%

Based on 11 completed trials

Completion Rate
79%(11/14)
Active Trials
2(9%)
Results Posted
36%(4 trials)
Terminated
3(13%)

Phase Distribution

Ph phase_4
6
26%
Ph phase_1
6
26%
Ph not_applicable
2
9%
Ph phase_3
4
17%
Ph phase_2
5
22%

Phase Distribution

6

Early Stage

5

Mid Stage

10

Late Stage

Phase Distribution23 total trials
Phase 1Safety & dosage
6(26.1%)
Phase 2Efficacy & side effects
5(21.7%)
Phase 3Large-scale testing
4(17.4%)
Phase 4Post-market surveillance
6(26.1%)
N/ANon-phased studies
2(8.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.3%

11 of 15 finished

Non-Completion Rate

26.7%

4 ended early

Currently Active

2

trials recruiting

Total Trials

23

all time

Status Distribution
Active(4)
Completed(11)
Terminated(4)
Other(4)

Detailed Status

Completed11
unknown4
Terminated3
Not yet recruiting2
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
2
Success Rate
78.6%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (26.1%)
Phase 25 (21.7%)
Phase 34 (17.4%)
Phase 46 (26.1%)
N/A2 (8.7%)

Trials by Status

active_not_recruiting14%
completed1148%
recruiting14%
withdrawn14%
terminated313%
not_yet_recruiting29%
unknown417%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT07305883Phase 3

Comparison of Intranasal Ketorolac and Intranasal Ketamine in Digital Nerve Block Pain

Not Yet Recruiting
NCT07180095Phase 1

Children of Age 2-6years Undergoing Elective Surgery Will be Divided Into Two Groups Randomly. This Study Aims to Evaluate if Intranasal Dexmedetomidine is Better Than Intranasal Ketamine in Producing Sedation and Reducing Parent Separation Anxiety Before Surgery.

Not Yet Recruiting
NCT07055828Not Applicable

Nebulized vs. IV Ketamine in Preventing Shivering Post Spinal Anesthesia

Active Not Recruiting
NCT04150757Phase 3

Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED

Terminated
NCT05934669Phase 4

IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED

Recruiting
NCT03781817Phase 4

Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures

Terminated
NCT05783492Phase 3

INK Feasibility Study

Withdrawn
NCT03539887Phase 3

Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse

Completed
NCT03146806Phase 1

Intranasal (NAS) Ketamine for Cancer Pain

Completed
NCT04352621Phase 4

Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)

Unknown
NCT03053947Phase 2

Pain Free Laceration Repairs Using Intra-nasal Ketamine

Completed
NCT02033434Phase 1

Pre-hospital Care With Intra-Nasal Ketamine for Transport (PRECINKT): A Pilot Study

Completed
NCT02447289Phase 4

Midazolam and Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment

Completed
NCT02206776Phase 2

Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD

Terminated
NCT02635282Phase 4

IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D

Completed
NCT02183272Phase 2

Emergency Ketamine Treatment of Suicidal Ideation

Unknown
NCT02839928Not Applicable

Nasal Ketamine for Minor Procedures in Children

Unknown
NCT01686009Phase 4

Intra-nasal Ketamine for Analgesia in the Emergency Department

Completed
NCT00451724Phase 2

Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair

Completed
NCT00520104Phase 1

Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
23